Testing an oral assessment guide during chemotherapy treatment in a Swedish care setting: a pilot study

P Andersson, Lena Persson, Ingalill Rahm Hallberg, S Renvert

Research output: Contribution to journalArticlepeer-review


Oral complications are common in patients with haematological malignancies who undergo chemotherapy treatment. A pilot study including 16 haematological patients was carried out to evaluate the oral status using an Oral Assessment Guide (OAG) and to test the reliability of the OAG. The oral assessments were made daily by registered nurses at a Department of Internal Medicine in Sweden. Once a week a dental hygienist made the oral assessments independent of the registered nurses in order to provide data for calculations of inter-rater reliability. All patients had varying degrees of alterations in the oral cavity, especially in the mucous membranes, teeth/dentures and gums. The inter-rater agreement between the nurses and the dental hygienist was good for saliva and swallow, and moderate for voice and gums. Assessments to detect alterations in the oral cavity afford the opportunity for early and individualized interventions and may decrease the risk of oral infections. It is necessary to train the nurses to ensure high levels of reliability in the oral assessments. The OAG seems to be a reliable and clinical useful tool for assessing the oral cavity status and determining changes.
Original languageEnglish
Pages (from-to)150-158
JournalJournal of Clinical Nursing
Issue number2
Publication statusPublished - 1999

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: The Vårdal Institute (016540000)

Subject classification (UKÄ)

  • Nursing


  • acute leukaemia
  • chemotherapy
  • Hodgkin's disease
  • myeloma
  • non-Hodgkin's lymphoma
  • nursing care
  • oral assessment guide
  • oral health


Dive into the research topics of 'Testing an oral assessment guide during chemotherapy treatment in a Swedish care setting: a pilot study'. Together they form a unique fingerprint.

Cite this